Merge Medical Startup Podcast

Merge Medical Startup Podcast

by Dr. Jeff Cole and Dr. Jeff Brown

Investing Medicine

Season 1

SOMAVAC: 10 in 10 Podcast

Is surgical drain management worthy of disruption? SOMAVAC is launching a deep tissue negative pressure device for large flaps (mastectomies and hernia repairs). FDA cleared for seroma prevention. Benefits to the patient & hospital/payor undeniable? “10 in 10” or quick hitting version of our video podcast. Drs Jeff Brown and Jeff Cole interview Esra Roan, PhD and Jane Berz, RN, MSN of SOMAVAC, an early-revenue company launching a deep tissue Negative Pressure Therapy device for large flaps created by plastic and general surgeries such as mastectomies and hernia repairs. The internationally patented SOMAVAC SVS delivers constant negative pressure therapy to effectively remove fluids and hold tissue layers together. The device is FDA cleared for seroma prevention. Early studies indicate earlier removal of surgical drains, which is known to correlate with infection rates, and overall fewer complications when compared to literature. The system is closed with one-click fluid disposal bags and markings eliminating the need to pour fluid in to measuring cup. SOMAVAC helps patients and their families recover with dignity after life-impacting surgeries. Significant savings to the hospital and health systems is projected within the immediate $550M market and $4.5B US addressable market. The closed system of fluid collection also allows SOMAVAC to crossover from the medtech to the biotech space potentially advancing science through the analysis of the seroma fluid collected postoperatively from the surgical site. This also extends the total addressable market to $15B. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

DIATECH DIABETES: Deep Dive Podcast

If the NIH and JDRF have given Diatech Diabetes the nod through funding…should this company be on your radar? SmartFusion™ is an infusion set failure detection system licensed as a SaaS algorithm to infusion device manufacturers. “Deep Dive” or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Diatech Diabetes founders John Wilcox and Luis Blanco. Diatech Diabetes is a medical device company committed to changing the way infusion set failure detection is done with their infusion set failure detection system, SmartFusion™. This is accomplished with a combination of real time data analysis and machine learning. SmartFusion™, is an infusion set failure detection system licensed as software-as-a-service to infusion device manufacturers. SmartFusion™ is an algorithm designed specifically for insulin (and other ambulatory drug delivery) pumps to detect different types of infusion failures not currently detected by insulin pumps on the market. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

DIATECH DIABETES: 10 in 10 Podcast

If the NIH and JDRF have given Diatech Diabetes the nod through funding…should this company be on your radar? SmartFusion™ is an infusion set failure detection system licensed as a SaaS algorithm to infusion device manufacturers. “10 in 10” or quick hitting version of our video podcast. Drs Jeff Brown and Jeff Cole interview Diatech Diabetes founders John Wilcox and Luis Blanco. Diatech Diabetes is a medical device company committed to changing the way infusion set failure detection is done with their infusion set failure detection system, SmartFusion™. This is accomplished with a combination of real time data analysis and machine learning. SmartFusion™, is an infusion set failure detection system licensed as software-as-a-service to infusion device manufacturers. SmartFusion™ is an algorithm designed specifically for insulin (and other ambulatory drug delivery) pumps to detect different types of infusion failures not currently detected by insulin pumps on the market. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

SUMMATE TECHNOLOGIES: Deep Dive Podcast

A WalMart type POS technology solution for the multi-billion dollar surgical industry. The Summate Trakker is the first & only scanning solution for ALL products used during a surgery, from both inside and outside the sterile field. Handwritten notes are still the norm? “Deep Dive” or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Phil Sayles, Founder and CEO of Summate Technologies. Summate has developed the Trakker™, a revolutionary POU tracking platform that leverages patented microchip tagging technology and workflow-friendly software. The Trakker is the first and only total consumption scanning solution for ALL products used during a surgical procedure, at the true point of use, from both inside and at the edge of the sterile field. The platform also delivers product intelligence and VOIP communication to field staff as well. It deploys two types of highly unique scanning technology. ***** Would this bring value to your medical practice, outpatient surgical center or hospital? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

SUMMATE TECHNOLOGIES: 10 in 10 Podcast

A WalMart type POS technology solution for the multi-billion dollar surgical industry. The Summate Trakker is the first & only scanning solution for ALL products used during a surgery, from both inside and outside the sterile field. Handwritten notes are still the norm? “10 in 10” or quick hitting version of our video podcast. Drs Jeff Brown and Jeff Cole interview Phil Sayles, Founder and CEO of Summate Technologies. Summate has developed the Trakker™, a revolutionary POU tracking platform that leverages patented microchip tagging technology and workflow-friendly software. The Trakker is the first and only total consumption scanning solution for ALL products used during a surgical procedure, at the true point of use, from both inside and at the edge of the sterile field. The platform also delivers product intelligence and VOIP communication to field staff as well. It deploys two types of highly unique scanning technology. ***** Would this bring value to your medical practice, outpatient surgical center or hospital? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

MEDSENDER: Deep Dive Podcast

With all of the modern day advances, the fax still lives on. The Medsender platform integrates with EMR/EHR systems applying AI, process automation and task management to incoming faxes and medical records. “Deep Dive” or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Salman Haque, one of 3 co-founders of Medsender. Medsender is a startup on a mission to automate healthcare administration. The Medsender platform integrates with electronic health record (EHR) systems and applies artificial intelligence and robotic process automation to enable medical practices to automate document workflows, such as filing incoming faxes, creating new patient charts, and assigning tasks in the EHR. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

MEDSENDER: 10 in 10 Podcast

With all of the modern day advances, the fax still lives on. The Medsender platform integrates with EMR/EHR systems applying AI, process automation and task management to incoming faxes and medical records. “10 in 10” or quick hitting version of our video podcast. Drs Jeff Brown and Jeff Cole interview Salman Haque, one of 3 co-founders of Medsender. Medsender is a startup on a mission to automate healthcare administration. The Medsender platform integrates with electronic health record (EHR) systems and applies artificial intelligence and robotic process automation to enable medical practices to automate document workflows, such as filing incoming faxes, creating new patient charts, and assigning tasks in the EHR. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

VITATEK: Partner Podcast

Merge Medical is proud to call VitaTek (formerly Vita Group) a partner and to offer their knowledge and capabilities to our community. VitaTek is a medical device incubator with vertical integration servicing every step from idea vetting to sales. More specifically, this includes in house R&D, prototyping, regulatory work, user testing, DFM, die mold creation, manufacturing, sterilization, distribution, and sales team access. Through growth and strategic acquisitions, VitaTek is largest private medical device manufacturer in the state of Minnesota with 150,000 sq-ft. Vita Group owns 11 medical device products; 4 are FDA approved and currently on the market. Four more devices will enter the market in 2024. ***** Would VitaTek bring value to your medical practice or personal innovative efforts? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

MICARE PATH: Deep Dive Podcast

MiCare Path is building a closer connection with an ever-growing population through its mobile health platform. Can personalized patient education and data-driven decisions result in better patient outcomes across multiple subspecialties? “Deep Dive” or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Scott Laster, one of 3 co-founders of MiCare Path. MiCare Path is building a closer connection with an ever-growing patient population, MiCare Path is a reimbursable integrated mobile health platform delivering improved outcomes with data-driven decisions, personalized patient education and care paths promoting clinical efficiencies for a better patient experience. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

MICARE PATH: 10 in 10 Podcast

MiCare Path is building a closer connection with an ever-growing population through its mobile health platform. Can personalized patient education and data-driven decisions result in better patient outcomes across multiple subspecialties? “10 in 10” or quick hitting version of our video podcast. Drs Jeff Brown and Jeff Cole interview Scott Laster, one of 3 co-founders of MiCare Path. MiCare Path is building a closer connection with an ever-growing patient population, MiCare Path is a reimbursable integrated mobile health platform delivering improved outcomes with data-driven decisions, personalized patient education and care paths promoting clinical efficiencies for a better patient experience. ***** Would this bring value to your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today! https://mergemedical.community.forum/ ***** DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

3 of 4